Back to BCAX
Ascent Group, LLC BCAX Position History
Bicara Therapeutics Inc. • Healthcare
Quarters held
11
Latest value
$28K
Q3 2026
Peak value
$375K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $238K |
| Q1 2026 | $281K |
| Q1 2026 | $318 |
| Q2 2026 | $208 |
| Q2 2026 | $39K |
| Q2 2026 | $375K |
| Q2 2026 | $6K |
| Q2 2026 | $475 |
| Q3 2026 | $932 |
| Q3 2026 | $248K |
| Q3 2026 | $28K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $28K | 1.5K | — | — |
| Q3 2026 | $248K | 13.3K | — | — |
| Q3 2026 | $932 | 50 | — | — |
| Q2 2026 | $475 | 16 | — | — |
| Q2 2026 | $6K | 187 | — | — |
| Q2 2026 | $375K | 12.6K | — | — |
| Q2 2026 | $39K | 1.3K | — | — |
| Q2 2026 | $208 | 7 | — | — |
| Q1 2026 | $318 | 16 | — | — |
| Q1 2026 | $281K | 14.1K | — | — |
| Q4 2025 | $238K | 14.2K | — | — |
Other funds holding BCAX
$93.9M
$63.1M
$60.8M
$60.8M
$54.4M
$53.4M
$50.1M